1. 股东大会届次：2025 年第一次临时股东大会。 2．股东大会的召集人：公司董事会。 证券代码：002898 证券简称：*ST 赛隆 公告编号：2025-051 赛隆药业集团股份有限公司 关于召开 2025 年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 赛隆药业集团股份有限公司（以下简称"公司"）于 2025 年 8 月 10 日召开 第四届董事会第十次会议，审议通过了《关于召开 2025 年第一次临时股东大会 的议案》，公司决定于 2025 年 8 月 26 日在珠海市香洲区南湾北路 31 号 2 单元 21 层公司会议室采取现场会议与网络投票相结合的方式召开 2025 年第一次临时 股东大会，现将有关事项通知如下： 一、召开会议的基本情况 3．会议召开的合法、合规性：本次股东大会的召开已经公司第四届董事会 第十次会议审议通过，符合公司法、《公司章程》等相关规定。 4．会议召开的日期、时间： （1）现场会议：2025 年 8 月 26 日（星期二）15:00 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时 ...

证券代码：002898 证券简称：*ST 赛隆 公告编号：2025-048 赛隆药业集团股份有限公司 第四届董事会第十次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 赛隆药业集团股份有限公司（以下简称"公司"）第四届董事会第十次会议 通知于 2025 年 8 月 8 日以书面方式通过专人送出、传真、电子邮件相结合的方 式送达各位董事。会议于 2025 年 8 月 10 日在珠海市香洲区南湾北路 31 号 2 单 元 21 层公司会议室以通讯方式召开，会议应到董事 9 人，实际出席董事 9 人， 会议由公司董事长蔡南桂先生主持，公司监事和高级管理人员列席本次会议。本 次会议的召集、召开和表决符合有关法律、行政法规、其他规范性文件和《公司 章程》的规定。 二、董事会会议审议情况 1.审议并通过了《关于补选公司第四届董事会非独立董事的议案》 鉴于公司控制权变更，非独立董事蔡南桂先生、唐霖女士、刘达文先生、李 剑峰先生、张旭女士、邓拥军先生申请辞去公司董事及相关专门委员会委员职务， 根据《公司法》和《公司章程》的有关规定，经公司 ...

Group 1 - Shenzhen Sailong Zhihui Technology Co., Ltd. has been established with a registered capital of 5 million RMB, fully owned by Sailong Pharmaceutical Group Co., Ltd. [1] - The legal representative of the new company is Zhang Xu [1]. - The business scope includes software and hardware retail and wholesale, technical services, cloud computing equipment sales and manufacturing, artificial intelligence system integration services, and various other technology-related services [2]. Group 2 - Sailong Pharmaceutical Group Co., Ltd. holds a 100% ownership stake in Shenzhen Sailong Zhihui Technology Co., Ltd. [2]. - The company is classified under the information transmission, software, and information technology services industry, specifically in software development [2]. - The registered address of the new company is located at Beiyou Technology Building, No. 42, High-tech South Ring Road, Nanshan District, Shenzhen [2].

New Stock Issuance - The new stock issuance for Zhigao Machinery (证券代码: 920101) is priced at 17.41 CNY per share, effective from August 5, 2025[1] - China Heavy Industry (证券代码: 601989) has a cash option declaration period from August 13, 2025[1] - China Shipbuilding (证券代码: 600150) has a buyback request period from August 13 to August 15, 2025[1] Offer and Acquisition Periods - Shenkou Co., Ltd. (证券代码: 002633) has a tender offer period from July 29 to August 27, 2025[1] - ST Kelly (证券代码: 300326) has a tender offer period from July 17 to August 15, 2025[1] - Happiness Blue Ocean (证券代码: 300528) has a significant announcement on July 30, 2025[1] Market Volatility - There are reports of severe abnormal fluctuations for Tibet Tourism (证券代码: 600749) as of July 31, 2025[1] - ST Suwu (证券代码: 600200) also reported significant volatility on July 30, 2025[1] - The stock of ST YaTai (证券代码: 000691) is under observation for abnormal trading activities as of August 5, 2025[1]

Group 1: New Stock Offerings - Shenke Co., Ltd. (002633) has a tender offer period from July 29, 2025, to August 27, 2025[1] - ST Kelly (300326) has a tender offer period from July 17, 2025, to August 15, 2025[1] - ST Zitian (300280) has a tender offer period ending on July 21, 2025[1] Group 2: Market Alerts - Xizang Tourism (600749) reported severe abnormal fluctuations on July 31, 2025[1] - Tianlu Convertible Bonds (110060) announced significant market activity on July 30, 2025[1] - ST Suwu (600200) experienced unusual trading patterns on July 30, 2025[1] Group 3: Additional Announcements - Happiness Blue Ocean (300528) issued a notice on July 30, 2025, regarding market conditions[1] - Common Pharmaceutical (300966) provided updates on August 1, 2025, related to stock performance[1] - Dongjie Intelligent (300486) released a statement on August 1, 2025, concerning market volatility[1]

证券代码：002898 证券简称：*ST 赛隆 公告编号：2025-046 赛隆药业集团股份有限公司 关于股票交易异常波动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别风险提示 1.赛隆药业集团股份有限公司（以下简称"公司"或"本公司"）股票（证 券简称：*ST 赛隆，证券代码：002898）于 2025 年 7 月 29 日、7 月 30 日、7 月 31 日连续 3 个交易日收盘价格涨幅累计偏离 12.64%，根据深圳证券交易所有关 规定，属于股票交易异常波动的情况。 2.公司于 2025 年 4 月 25 日披露了《2024 年年度报告》，经审计的年度报 告数据显示，公司 2024 年度利润总额、净利润、扣除非经常性损益后的净利润 三者均为负值，且扣除后的营业收入低于 3 亿元。根据《深圳证券交易所股票上 市规则》第 9.3.1 条规定，公司股票交易于 2025 年 4 月 28 日被深圳证券交易所 实施退市风险警示。若公司 2025 年度出现《深圳证券交易所股票上市规则》第 9.3.12 条所规定的关于终止公司股票上市交易的相关情形之一， ...

Group 1 - The company announced a change of registered address for its wholly-owned subsidiary, Hunan Sailong Pharmaceutical Co., Ltd., due to operational development needs [1] - The new registered address is located at the Economic and Technological Development Zone in Wangcheng, Changsha City, Hunan Province [1] - The company has completed the relevant industrial and commercial registration procedures and obtained a new business license approved by the Wangcheng Economic and Technological Development Zone Management Committee [1] Group 2 - Hunan Sailong Pharmaceutical Co., Ltd. is a limited liability company with a registered capital of 28 million yuan [1] - The company was established on April 13, 2007, and its legal representative is Long Zhixiang [1] - The business scope includes the production and sales of various pharmaceutical products, including sterile raw materials and medical devices, as well as research and development activities [1]

证券代码：002898 证券简称：*ST 赛隆 公告编号：2025-045 赛隆药业集团股份有限公司 关于全资子公司变更注册地址并完成工商登记 的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 赛隆药业集团股份有限公司（以下简称"公司"）于 2025 年 7 月 25 日收到 全资子公司湖南赛隆药业有限公司（以下简称"湖南赛隆"）的通知，因经营发 展的需要，湖南赛隆对注册地址进行了变更，并完成了相关工商变更登记手续， 取得了望城经济技术开发区管理委员会核准换发的《营业执照》。具体情况如下： | 一、变更情况 | | --- | | | 湖南省华容县工业园 | 市望城区望联建设开发有限公司 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 登记事项 住所 | 变更前内容 | 变更后内容 长沙市望城经济技术开发区长沙 企业配套中心 | 1 | 楼 | 101 | 室 | 10 | 房 | 二、变更后的工商登记基本情况 名称：湖南赛隆药业有限公司 类型：有限责任公司( ...

New Stock Issuance - Multiple companies are scheduled for new stock issuance on July 24, 2025, including *ST Zitian (300280) and ST Nanzhi (002305) [1] - Significant announcements were made for companies like Guosheng Tang (300436) and Huayin Power (600744) on July 17 and July 15, respectively [1] Trading Alerts - Companies such as Gaoguan Min Explosive (002827) and Zhongyan Dadi (003001) have recent trading alerts as of July 24, 2025 [1] - A total of 50 companies have been flagged for abnormal trading fluctuations, indicating potential market volatility [2] Market Trends - The report highlights a trend of increased market activity with numerous companies announcing significant changes in stock status [1] - The presence of multiple *ST (Special Treatment) companies suggests heightened scrutiny and potential risk for investors [1] Regulatory Compliance - Companies are required to disclose significant announcements to ensure transparency in trading activities [1] - The report emphasizes the importance of monitoring announcements to assess market conditions and investment risks [1]

New Stock Listings - Tech Source Group issued shares at a price of 10.88 CNY[1] - Shanda Power issued shares at a price of 14.66 CNY[1] Market Alerts - ST Zitian reported an equity date on July 21, 2025, with a link to the announcement[1] - Guangshengtang experienced severe abnormal fluctuations, with an announcement on July 17, 2025[1] - Huayin Power had an announcement on July 15, 2025, regarding market conditions[1] - Multiple companies including Shangwei New Materials, China Power Construction, and Jiangnan Chemical had announcements on July 23, 2025, regarding market activities[1] Abnormal Fluctuations - Companies such as ST Weier and ST Huadong reported significant fluctuations with announcements on July 21, 2025[2] - ST Jinyi and ST Yundong also reported abnormal fluctuations with announcements on July 17, 2025[2]